Have a personal or library account? Click to login
Non Invasive Prenatal Diagnosis of Aneuploidy: Next Generation Sequencing or Fetal DNA Enrichment? Cover

Non Invasive Prenatal Diagnosis of Aneuploidy: Next Generation Sequencing or Fetal DNA Enrichment?

Balkan Journal of Medical Genetics
Volume 15 (2012): Issue Supplement (December 2012)
By: Neil D. Avent,  A Webb,  TE Madgett,  T Miran,  K Sillence,  N Kaushik and  M Kiernan  
Open Access
|Dec 2012

References

  1. 1. NHS FASP, 2010. NHS Fetal Anomaly Screening Programme Annual Report 2009-2010. Available at [http://fetalanomaly.screening.nhs.uk/getdata. php?id=11354] Accessed on January 16 2012.
    Search in Google Scholar
  2. 2. Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling. Obstet Gynecol. 2007; 110(3): 687-694.10.1097/01.AOG.0000278820.54029.e3
    Search in Google Scholar
  3. 3. Go AT, van Vugt JMG, Oudejans CBM. Noninvasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities. Hum Reprod Update. 2011; 17(3): 372-382.10.1093/humupd/dmq054
    Search in Google Scholar
  4. 4. Hahn S, Lapaire O, Tercanli S, Kolla V, Hösli I. 2011. Determination of fetal chromosome aberrations from fetal DNA in maternal blood: has the challenge finally been met? Expert Rev Molec Med. 2011; 13; 16: e16. Available at [http://www.ncbi.nlm.nih.gov/pmc/ articles/ PMC3087311/pdf/S1462399411001852a. pdf] Accessed on January 16 2012.10.1017/S1462399411001852
    Search in Google Scholar
  5. 5. Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn. 2011; 31(1): 7-15.10.1002/pd.2637
    Search in Google Scholar
  6. 6. NHS, 2010. When an abortion should be carried out. Available at [http://www.nhs.uk/Conditions/ Abortion/ Pages/When-should-it-be-done.aspx] Accessed on January 8 2012.
    Search in Google Scholar
  7. 7. Bischoff FZ, Sinacori MK, Dang DD, et al. Cell-free fetal DNA and intact fetal cells in maternal blood circulation: implications for first and second trimester non-invasive prenatal diagnosis. Hum Reprod Update. 2001; 8(6): 493-500.10.1093/humupd/8.6.493
    Search in Google Scholar
  8. 8. Chitty LS, van der Schoot CE, Hahn S, Avent ND. SAFE-The special non-invasive advances in fetal and neonatal evaluation network: aims and achievements. Prenat Diagn. 2009; 28(2): 83-88.10.1002/pd.1929
    Search in Google Scholar
  9. 9. Maddocks DG, Alberry MS, Attilakos G, et al. The SAFE project-towards non-invasive prenatal diagnosis. Biochem Soc Transactions. 2009; 37: 460-465.10.1042/BST0370460
    Search in Google Scholar
  10. 10. Lo YMD, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350(9076): 485-487.10.1016/S0140-6736(97)02174-0
    Search in Google Scholar
  11. 11. Lo YMD. Non-invasive prenatal diagnosis using fetal cells in maternal blood. J Clin Pathol. 1994; 47(12): 1060-1065.10.1136/jcp.47.12.10605021937876375
    Search in Google Scholar
  12. 12. Herzenburg LA, Bianchi DW, Schroder J, Cann HM, Iverson GM. Fetal cells in the blood of pregnant women: Detection and enrichment by fluorescenceactivated cell sorting. Proc Natl Acad Sci USA. 1979; 76(3): 1453-1455.10.1073/pnas.76.3.1453383270286330
    Search in Google Scholar
  13. 13. Avent ND, Plummer ZE, Madgett TE, et al. Postgenomics studies and their application to non-invasive prenatal diagnosis. Semin Fetal Neonat Med. 2008; 13: 91-98.10.1016/j.siny.2007.12.01118249591
    Search in Google Scholar
  14. 14. Wapner RJ. Invasive prenatal diagnostic techniques. Semin Perinatol. 2005; 29(6): 401-404.10.1053/j.semperi.2006.01.00316533654
    Search in Google Scholar
  15. 15. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA. 1996; 93(2): 705-708.10.1073/pnas.93.2.705401178570620
    Search in Google Scholar
  16. 16. Illanes S, Denbow M, Kailasam C, Finning K, Soothill PW. Early detection of cell-free fetal DNA in maternal plasma. Early Hum Dev. 2007; 83(9): 563-566.10.1016/j.earlhumdev.2006.11.00117234369
    Search in Google Scholar
  17. 17. Lo YMD, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet. 1999; 64(1): 218-224.10.1086/30220513777209915961
    Search in Google Scholar
  18. 18. Avent ND, Finning KM, Martin PG, Soothill PW. Prenatal determination of fetal blood group status. Vox Sang. 2000; 78(2): 155-162.
    Search in Google Scholar
  19. 19. Finning KM, Martin PG, Soothill PW, Avent ND. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion. 2002; 42(8): 1079-1085.10.1046/j.1537-2995.2002.00165.x12385421
    Search in Google Scholar
  20. 20. Scheffer PG, van der Schoot CE, Page-Christiaens GCML, de Haas M. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7 year clinical experience; Br J Obstet Gynaecol. 2011; 118(11): 1340-1348.
    Search in Google Scholar
  21. 21. Avent ND, Chitty LS. Non-invasive diagnosis of fetal sex; utilisation of free fetal DNA in maternal plasma and ultrasound. Prenat Diagn. 2006; 26(7): 598-603.10.1002/pd.149316856214
    Search in Google Scholar
  22. 22. Poon LLM, Leung TN, Lau TK, Chow KCK, Lo YMD. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin Chem. 2002; 48(1): 35-41.10.1093/clinchem/48.1.35
    Search in Google Scholar
  23. 23. Tsui NBY, Ng EKO, Lo YMD. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem. 2002; 48(10): 1647-1653.10.1093/clinchem/48.10.1647
    Search in Google Scholar
  24. 24. Chiu RW, Lui WB, Cheung MC. et al. Time profile of appearance and disappearance of circulating placenta-derived mRNA in maternal plasma. Clin Chem. 2006; 52(2): 313-316.10.1373/clinchem.2005.05969116449214
    Search in Google Scholar
  25. 25. Ng EKO, Tsui NBY, Lau TK, et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA. 2003; 100(8): 4748-4753.10.1073/pnas.063745010015362712644709
    Search in Google Scholar
  26. 26. Lo YMD, Tsui NBY, Chiu RWK, et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med. 2007; 13(2): 218-223.10.1038/nm153017206148
    Search in Google Scholar
  27. 27. Lo YMD. Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art. Br J Obstet Gynaecol. 2008; 116(2): 152-157.
    Search in Google Scholar
  28. 28. Lo YMD, Lun FMF, Chan KCA, et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA. 2007; 104(32): 13116-13121.10.1073/pnas.0705765104193492317664418
    Search in Google Scholar
  29. 29. Chim SSC, Tong YK, Chiu RWK, et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci USA. 2005; 102(41): 14753-14758.10.1073/pnas.0503335102125354716203989
    Search in Google Scholar
  30. 30. Tong YK, Ding C, Chiu RWK, et al. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations. Clin Chem. 2006; 52(12): 2194-2202.10.1373/clinchem.2006.07685117040955
    Search in Google Scholar
  31. 31. Weber M, Davies JJ, Wittig D, et al. Chromosomewide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet. 2005; 37(8): 853-62.10.1038/ng159816007088
    Search in Google Scholar
  32. 32. Papageorgiou EA, Fiegler H, Rakyan V, et al. Sites of Differential DNA Methylation between Placenta and Peripheral Blood: Molecular Markers for Noninvasive Prenatal Diagnosis of Aneuploidies. Am J Pathol. 2009; 174(5): 1609-1618.10.2353/ajpath.2009.081038267125019349366
    Search in Google Scholar
  33. 33. Lun FMF, Chiu RWK, Chan KCA, et al. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem. 2008; 54(10): 1664-1672.10.1373/clinchem.2008.11138518703764
    Search in Google Scholar
  34. 34. Tong YK, Jin S, Chiu RWK, et al. Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clin Chem. 2010; 56(1): 90-98.10.1373/clinchem.2009.13411419850629
    Search in Google Scholar
  35. 35. Tsui DWY, Lam YMD, Lee WS, et al. Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edward’s syndrome. PLoS One 2010; 5(11): e15069.10.1371/journal.pone.0015069299481021152411
    Search in Google Scholar
  36. 36. Vogelstein B, Kinzler KW. 1999. Digital PCR. Proc Natl Acad Sci USA. 1999; 96(16): 9236-9241.
    Search in Google Scholar
  37. 37. Zimmermann BG, Grill S, Holzgreve W, et al. Digital PCR: a powerful new tool for noninvasive prenatal diagnosis? Prenat Diagn. 2008; 28(12): 1087-1093.10.1002/pd.215019003785
    Search in Google Scholar
  38. 38. Fan HC, Quake SR. Detection of aneuploidy with digital polymerase chain reaction. Anal Chem. 2007; 79(19): 7576-7579.10.1021/ac070939417715994
    Search in Google Scholar
  39. 39. Fan HC, Blumenfeld YJ, Chitkara U, et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA. 2008; 105(42): 16266-16271.10.1073/pnas.0808319105256241318838674
    Search in Google Scholar
  40. 40. Chen EZ, Chiu RWK, Sun H, et al. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011; 6(7): e21791.10.1371/journal.pone.0021791313077121755002
    Search in Google Scholar
  41. 41. Ehrich M, Deciu C, Zwiefelhofer T, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol. 2011; 204(3): 205.e1-11.10.1016/j.ajog.2010.12.06021310373
    Search in Google Scholar
  42. 42. Chiu RWK, Chan KCA, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA. 2008; 105(51): 20458-20463.10.1073/pnas.0810641105260058019073917
    Search in Google Scholar
  43. 43. van den Oever JM, Balkassmi S, Verweij EJ, et al. Single molecule sequencing of free DNA from maternal plasma for noninvasive trisomy 21 detection. Clin Chem. 2012; 58(4): 699-706.10.1373/clinchem.2011.17469822278607
    Search in Google Scholar
  44. 44. Avent ND. Refining noninvasive prenatal diagnosis with single-molecule next generation sequencing. Clin Chem. 2012; 58(4): 657-658.10.1373/clinchem.2011.18138822300629
    Search in Google Scholar
  45. 45. Dhallan R, Au WC, Mattagajasingh S, et al. Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. JAMA. 2004; 291(9): 1114-1119.10.1001/jama.291.9.111414996781
    Search in Google Scholar
  46. 46. Chung GTY, Chiu RWK, Chan KCA, et al. Lack of dramatic enrichment of fetal DNA in maternal plasma by formaldehyde treatment. Clin Chem. 2005; 51(3): 655-658.10.1373/clinchem.2004.04216815738522
    Search in Google Scholar
  47. 47. Chinnapapagari SKR, Holzgreve W, Lapaire O, et al. Treatment of maternal blood samples with formaldehyde does not alter the proportion of circulatory fetal nucleic acid (DNA and RNA) in maternal plasma. Clin Chem. 2005; 51(3): 652-655.10.1373/clinchem.2004.04211915738521
    Search in Google Scholar
  48. 48. Li Y, Zimmermann B, Rusterholz C, et al. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem. 2004; 50(6): 1002-1011.10.1373/clinchem.2003.02983515073090
    Search in Google Scholar
  49. 49. Chan KCA, Zhang J, Hui ABY, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem. 2004; 50(1): 88-92.10.1373/clinchem.2003.02489314709639
    Search in Google Scholar
  50. 50. Li Y, Di Naro E, Vitucci A, et al. Detection of paternally inherited fetal point mutations for b-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA. 2005; 293(7): 843-849.10.1001/jama.293.7.84315713774
    Search in Google Scholar
  51. 51. Li J, Wang L, Mamon H, et al. Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing. Nat Med. 2008; 14(5): 579-584.10.1038/nm170818408729
    Search in Google Scholar
  52. 52. Li J, Makrigiorgos GM. COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing. Biochem Soc Transactions. 2009; 37(2): 427-432.10.1042/BST037042719290875
    Search in Google Scholar
  53. 53. Kolialexi A, Tsangaris GT, Papantoniou N, et al. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma. Prenat Diagn. 2008; 28(8): 691-698.10.1002/pd.204018551720
    Search in Google Scholar
  54. 54. Choolani M, Narasimkhan K, Kolla V, Hahn S. Proteomic technologies for prenatal diagnostics: advances and challenges ahead. Expert Rev Proteomics. 2009; 6: 87-101.10.1586/14789450.6.1.8719210129
    Search in Google Scholar
  55. 55. Tsangaris GT, Karamessinis P, Kolialexi A, et al. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics. 2006; 6(15): 4410-4419.10.1002/pmic.20060008516847874
    Search in Google Scholar
  56. 56. Nagalla SR, Canick JA, Jacob T, et al. Proteomic analysis of maternal serum in Down syndrome: identification of novel protein biomarkers. J Proteome Res. 2007; 6: 1245-1257.10.1021/pr060539h17373838
    Search in Google Scholar
  57. 57. Kolla V, Jenö P, Moes S, et al. Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ). J Biomed Biotechnol. 2010; 2010: 952047 [Epub 2009 Nov 5].
    Search in Google Scholar
  58. 58. Heywood WE, Madgett TE, Wang D, et al. 2D-DIGE analysis of maternal plasma for potential biomarkers for Down syndrome. Proteome Sci. 2011; 9: 56.10.1186/1477-5956-9-56318987221929753
    Search in Google Scholar
  59. 59. Heywood WE, Mills K, Wang D, et al. Identification of new biomarkers for Down’s syndrome in maternal plasma. J Proteomics. 2012; in press.10.1016/j.jprot.2012.03.00722456345
    Search in Google Scholar
  60. 60. Heywood WE, Wang D, Madgett TE, et al. The development of a peptide -SRM based tandem mass spectrometry assay for prenatal screening of Down syndrome. J Proteomics. 2012; in press. 10.1016/j.jprot.2012.03.03722543281
    Search in Google Scholar
DOI: https://doi.org/10.2478/v10034-012-0013-z | Journal eISSN: 2199-5761
Journal RSS Feed
Language: English
Page range: 17 - 26
Published on: Dec 22, 2012
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Aneuploidy,
Cell free fetal DNA (cff DNA),
Non invasive prenatal diagnosis (NIPD)
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2012 Neil D. Avent, A Webb, TE Madgett, T Miran, K Sillence, N Kaushik, M Kiernan, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons License.

Previous articleVolume 15 (2012): Issue Supplement (December 2012)Next article